Serum determination of antiphospholipid antibodies (anticardiolipin and anti-beta 2 glycoprotein antibodies), molecular testing, and CD55 and CD59 flow cytometry are not affected by acute thrombosis or anticoagulant treatment [6,13,62,63]. This evidence concerns the gene CD59 and Venous thrombosis.